Metallothionein Isoform 3 Overexpression Is Associated with Breast Cancers Having a Poor Prognosis

作者: Mary Ann Sens , Seema Somji , Scott H. Garrett , C. Larry Beall , Donald A. Sens

DOI: 10.1016/S0002-9440(10)61668-9

关键词:

摘要: The third isoform (MT-3) of the metallothionein gene family is unique in that it has a limited tissue distribution, not induced by metals, neuronal growth inhibitory activity, and sequesters zinc more effectively under zinc-depleted conditions. goal present study was to determine whether MT-3 absent normal breast tissue, overexpressed cancers, if overexpression would be associated with disease outcome. A combination immunohistochemistry reverse-transcription polymerase chain reaction used demonstrate had no detectable expression mRNA or protein. Using immunohistochemistry, shown 25 34 cases cancer. In all positive staining, diffusely localized cytoplasm. tumors from these were divided as outcome based on known 5-year survival, 20 patients being free at 5 years (good outcome) other 14 having recurring within (bad outcome). When analyzed for there trend increased immunoreactivity group bad outcomes. However, when tumor subgrouping further defined basis carcinoma situ (CIS), marked significant difference staining between good Limited DCIS, significantly outcomes compared those Thus, studies selected cancers poor prognosis.

参考文章(20)
Pierre Hainaut, Jo Milner, A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Research. ,vol. 53, pp. 1739- 1742 ,(1993)
C. Jacob, W. Maret, B. L. Vallee, Control of zinc transfer between thionein, metallothionein, and zinc proteins Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 3489- 3494 ,(1998) , 10.1073/PNAS.95.7.3489
S Detre, G Saclani Jotti, M Dowsett, A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. Journal of Clinical Pathology. ,vol. 48, pp. 876- 878 ,(1995) , 10.1136/JCP.48.9.876
Scott H. Garrett, Mary Ann Sens, John H. Todd, Seema Somji, Donald A. Sens, Expression of MT-3 protein in the human kidney Toxicology Letters. ,vol. 105, pp. 207- 214 ,(1999) , 10.1016/S0378-4274(99)00003-X
Scott H. Garrett, Mary Ann Sens, Deepti Shukla, Scott Nestor, Seema Somji, John H. Todd, Donald A. Sens, Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines. The Prostate. ,vol. 41, pp. 196- 202 ,(1999) , 10.1002/(SICI)1097-0045(19991101)41:3<196::AID-PROS7>3.0.CO;2-U
Glen K Andrews, Regulation of metallothionein gene expression by oxidative stress and metal ions Biochemical Pharmacology. ,vol. 59, pp. 95- 104 ,(2000) , 10.1016/S0006-2952(99)00301-9
M A Sens, S Somji, D L Lamm, S H Garrett, F Slovinsky, J H Todd, D A Sens, Metallothionein isoform 3 as a potential biomarker for human bladder cancer. Environmental Health Perspectives. ,vol. 108, pp. 413- 418 ,(2000) , 10.1289/EHP.00108413
R. D. Palmiter, S. D. Findley, T. E. Whitmore, D. M. Durnam, MT-III, a brain-specific member of the metallothionein gene family Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 6333- 6337 ,(1992) , 10.1073/PNAS.89.14.6333